Tetrazole: A privileged scaffold for the discovery of anticancer agents

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Oncology

Background:

• Carcinoma remains a leading global cause of mortality, driven by carcinogenic factors.
• Existing anticancer agents face challenges of drug resistance and high costs.
• Novel therapeutic strategies are crucial for effective cancer treatment.

Purpose of the Study:

• To review synthetic approaches for tetrazole analogs.
• To identify cancer targets for tetrazole-based therapies.
• To summarize the biological activities of recent tetrazole-containing anticancer agents.

Main Methods:

• Literature review of synthetic methodologies for tetrazole compounds.
• Analysis of studies on tetrazole derivatives as anticancer agents.
• Compilation of data on biological activities and cancer targets.

Main Results:

• Tetrazole ring systems are promising scaffolds for developing new anticancer drugs.
• Various synthetic routes enable the creation of diverse tetrazole analogs.
• Several tetrazole-containing compounds exhibit significant anticancer activity against various cancer types.

Conclusions:

• Tetrazole derivatives represent a valuable class of compounds for novel anticancer drug discovery.
• Further research into tetrazole synthesis and biological evaluation can lead to improved cancer therapies.
• Tetrazole-based agents offer a potential alternative to existing treatments, addressing resistance and cost concerns.